Skip to main content
. 2009 Dec 16;8:36. doi: 10.1186/1476-0711-8-36

Table 1.

Frequency of HGV RNA, Anti E2, HBsAg, HbcAB, HCV RNA and Anti HCV in patients and controls.

HGV Exposure HGV/RNA Anti E2 HbsAg HBcAB HCV RNA Anti HCV
Haemodialysis(34)
Predialysis (66)
23(67.6%)
28(42.4%)
9 (26.5%)
9 (13.6%)
14 (41.2%)
19 (28.8%)
2 (5.9%)
3 (4.5%)
2 (5.9%)
3 (4.5%)
33 (97%)
25 (37.9%)
32 (94.1%)
20 (30.3%)
Total (100) 51 (51%) 18 (18%) 33 (33%) 5 (5%) 5 (5%) 58 (58%) 52 (52%)

Controls (25) 2 (8%) 1 (4%) 1 (4%) 0 0 0 0